Arimond Mary, Zeilani Mamane, Jungjohann Svenja, Brown Kenneth H, Ashorn Per, Allen Lindsay H, Dewey Kathryn G
Department of Nutrition, University of California, Davis, Davis, California, USA.
Program in International and Community Nutrition, University of California, Davis, Davis, California, USA.
Matern Child Nutr. 2015 Dec;11 Suppl 4(Suppl 4):31-61. doi: 10.1111/mcn.12049.
The International Lipid-Based Nutrient Supplements (iLiNS) Project began in 2009 with the goal of contributing to the evidence base regarding the potential of lipid-based nutrient supplements (LNS) to prevent undernutrition in vulnerable populations. The first project objective was the development of acceptable LNS products for infants 6-24 months and for pregnant and lactating women, for use in studies in three countries (Burkina Faso, Ghana and Malawi). This paper shares the rationale for a series of decisions in supplement formulation and design, including those related to ration size, ingredients, nutrient content, safety and quality, and packaging. Most iLiNS supplements have a daily ration size of 20 g and are intended for home fortification of local diets. For infants, this ration size is designed to avoid displacement of breast milk and to allow for dietary diversity including any locally available and accessible nutrient-dense foods. Selection of ingredients depends on acceptability of flavour, micronutrient, anti-nutrient and essential fatty acid contents. The nutrient content of LNS designed to prevent undernutrition reflects the likelihood that in many resource-poor settings, diets of the most nutritionally vulnerable individuals (infants, young children, and pregnant and lactating women) are likely to be deficient in multiple micronutrients and, possibly, in essential fatty acids. During ingredient procurement and LNS production, safety and quality control procedures are required to prevent contamination with toxins or pathogens and to ensure that the product remains stable and palatable over time. Packaging design decisions must include consideration of product protection, stability, convenience and portion control.
国际脂质基营养补充剂(iLiNS)项目始于2009年,目标是为脂质基营养补充剂(LNS)预防弱势群体营养不良的潜力提供证据支持。该项目的首要目标是开发适合6至24个月婴儿以及孕妇和哺乳期妇女的可接受的LNS产品,用于在三个国家(布基纳法索、加纳和马拉维)开展的研究。本文阐述了在补充剂配方和设计中一系列决策的依据,包括与定量大小、成分、营养成分、安全性和质量以及包装相关的决策。大多数iLiNS补充剂的每日定量为20克,旨在对当地饮食进行家庭强化。对于婴儿而言,这种定量设计是为了避免替代母乳,并允许饮食多样化,包括任何当地可得且易获取的营养丰富的食物。成分的选择取决于风味、微量营养素、抗营养素和必需脂肪酸含量的可接受性。旨在预防营养不良的LNS的营养成分反映出,在许多资源匮乏的环境中,营养最易受影响的人群(婴儿、幼儿以及孕妇和哺乳期妇女)的饮食可能缺乏多种微量营养素,甚至可能缺乏必需脂肪酸。在成分采购和LNS生产过程中,需要安全和质量控制程序来防止毒素或病原体污染,并确保产品随着时间推移保持稳定且可口。包装设计决策必须考虑产品保护、稳定性、便利性和分量控制。